RecruitingNot ApplicableNCT05168605
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
Sponsor
University of Texas Southwestern Medical Center
Enrollment
100 participants
Start Date
Jul 27, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The purpose of study is to evaluate whether home visit programs are an effective method for HTN and T2DM management as compared to standard of care clinic visits.
Eligibility
Min Age: 18 YearsMax Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether targeted home visits by healthcare workers can help adults better manage two common chronic conditions — high blood pressure (hypertension) and poorly controlled diabetes — in underserved communities.
**You may be eligible if...**
- You are an adult aged 18–60 years
- You speak English or Spanish
- You have a diagnosis of high blood pressure, or a blood pressure reading above 140/90 mmHg in the past 3 months
- Your HbA1c (a measure of blood sugar control) was above 8% in the past 6 months
**You may NOT be eligible if...**
- You currently take oral steroids regularly
- You have had a solid organ transplant
- You speak a language other than English or Spanish
- You are pregnant
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERHome visit
Patients receiving home Visits
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05168605
Related Trials
Supporting VETerans With Kidney Disease Through Food As Medicine
NCT071947331 location
Genetics of Type 2 Diabetes in West Africans
NCT008371225 locations
Spyral InSight Study
NCT070139292 locations
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Manganese-enhanced Magnetic Resonance Imaging (MEMRI) in Heart Failure With Preserved Ejection Fraction
NCT066527631 location